Feinendegen D L, Ohlenschlaeger U, Grossmann K, Holschbach M, Shreeve W W, Feinendegen L E
Institute of Medicine and Chemistry, Research Center Juelich, Germany.
J Nucl Med. 1996 Nov;37(11):1841-5.
The two radioiodinated fatty acid analogs 15-(para-131 I-phenylpentadecanoic acid (pPPA) and 15-(ortho-131I-phenyl)-pentadecanoic acid (oPPA) are isomers with individually different routes in lipid metabolism but with near equal transport kinetics into tissue.
Normal adult male Wistar rats (n = 79) and those with liver cell damage from adriamycin treatment (n = 84) received 1.48- 1.85 MBq 131I-pPPA or 131I-oPPA (specific activity, 33.3-46.3 GBq/microM) into the jugular vein. At 1, 2, 3, 5, 7, 10 and 20 min, livers of up to five animals per group were examined for total tracer uptake and tracer incorporation into various lipid fractions.
Uptake of both isomers into the total liver plateaued at about 2 min; the ratio oPPA/pPPA in normal liver averaged 2.63 and was significantly higher than the average ratio of 1.50 after adriamycin treatment. This fall in ratio was mainly due to an increase of pPPA uptake. Significant differences of the respective ratios were found in the plateau for the phospholipids (9.7 versus 3.0), cholesterol (2.4 versus 0.7) and triglycerides (2.0 versus 0.4).
The dual-tracer technique with pPPA and oPPA promises to be clinically useful for the diagnosis of liver disease by imaging the ratios of tracer uptake in the total liver and by in vitro analysis of the uptake ratio in serum triglycerides.
两种放射性碘化脂肪酸类似物15-(对-131I-苯基十五烷酸(pPPA)和15-(邻-131I-苯基)-十五烷酸(oPPA)是异构体,在脂质代谢中具有各自不同的途径,但进入组织的转运动力学近乎相等。
正常成年雄性Wistar大鼠(n = 79)和经阿霉素治疗导致肝细胞损伤的大鼠(n = 84)经颈静脉注射1.48 - 1.85 MBq的131I-pPPA或131I-oPPA(比活度,33.3 - 46.3 GBq/μM)。在1、2、3、5、7、10和20分钟时,每组最多五只动物的肝脏用于检测总示踪剂摄取以及示踪剂掺入各种脂质组分的情况。
两种异构体在整个肝脏中的摄取在约2分钟时达到平台期;正常肝脏中oPPA/pPPA的比值平均为2.63,显著高于阿霉素治疗后的平均比值1.50。该比值下降主要是由于pPPA摄取增加。在磷脂(9.7对3.0)、胆固醇(2.4对0.7)和甘油三酯(2.0对0.4)的平台期发现了各自比值的显著差异。
pPPA和oPPA的双示踪技术有望通过对整个肝脏中示踪剂摄取比值进行成像以及对血清甘油三酯中的摄取比值进行体外分析,在临床上用于肝病的诊断。